Essex Investment Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
NAMA
CIP
Essex Investment Management's VCYT Position: Q1 2024 in Review
Essex Investment Management sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 112,934 shares — an estimated $3.11M sold.
Essex Investment Management first reported a position in VCYT in Q3 2017 and held it in 26 quarters. The position peaked at $7.8M in Q1 2019. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.
- Essex Investment Management reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
- Essex Investment Management sold 112,934 Veracyte shares in Q1 2024, an estimated $3.11M.
- Essex Investment Management first reported a position in Veracyte in Q3 2017 and held it in 26 quarters.
- Essex Investment Management's Veracyte position peaked at $7.8M in Q1 2019.
- 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.
Based on Essex Investment Management's 13F filing for Q1 2024, filed 3 May 2024.